ODDB.org: Open Drug Database

AstraZeneca AG - Tezspire, Injektionslösung in einer Fertigspritze

Swissmedic Registration	68454	Sequence	01
Product name	Tezspire	Description	Injektionslösung in einer Fertigspritze
ATC-Classification	R03DX11	ATC-Description	Tezepelumab
Introduction of Sequence	13.06.2022

Composition

tezepelumabum 210 mg, prolinum, acidum aceticum glaciale, polysorbatum 80, natrii hydroxidum q.s. ad pH, aqua ad iniectabile, ad solutionem pro 1.91 ml.

Packungsbestandteile

Galenic Form

Injection solution in prefilled syringe

Excipiens

Active Agent	Dose
Tezepelumabum	210 mg

BAG: Active Agent	Dose
Tezepelumabum	210 mg

Inactive agents
Acidum Aceticum Glaciale
Sodium Hydroxide
Polysorbatum 80
Proline

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		1036.42	1143.60	B	SL	No

2025	©ywesee GmbH